Literature DB >> 513194

Species specificity of interferon action: maintenance and establishment of the antiviral state in the presence of a heterospecific nucleus.

M J Veomett, G E Veomett.   

Abstract

The expression of the interferon-induced antiviral state was studied in heterokaryons and cytoplasmic hybrids (cybrids). An autoradiographic assay for the antiviral state, in which the percentage of cells containing vaccinia viral DNA factories was determined, was used. The expression of the antiviral state was dominant in homokaryons and heterokaryons formed by fusion of interferon-treated cells with untreated cells. Cytoplasts derived from treated cells conferred resistance to virus growth on cybrids formed by fusing such cytoplasts with untreated cells. Treatment of L cell x HeLa cell heterokaryons with human interferon or mouse interferon was much less effective in inducing a detectable antiviral state than was similar treatment of parental cells with homospecific interferon. The antiviral state was fully induced when heterokaryons were treated simultaneously with both types of interferon. Cybrids formed by fusing L cell cytoplasts with HeLa cells or HeLa cytoplasts with L cells did not enter a detectable antiviral state after treatment with interferon specific for the cell type of the enucleated parent. However, treatment of cybrids with interferon specific for the cell type of the nucleated parent was effective in inducing a detectable antiviral state.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 513194      PMCID: PMC353506     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  25 in total

1.  INHIBITION OF INTERFERON ACTION BY P-FLUOROPHENYLALANINE.

Authors:  R M FRIEDMAN; J A SONNABEND
Journal:  Nature       Date:  1964-07-25       Impact factor: 49.962

2.  STUDIES ON THE MECHANISM OF ACTION OF INTERFERON. I. INTERFERON ACTION AND RNA SYNTHESIS IN CHICK EMBRYO FIBROBLASTS INFECTED WITH SEMLIKI FOREST VIRUS.

Authors:  J TAYLOR
Journal:  Virology       Date:  1965-03       Impact factor: 3.616

3.  INTERFERON INHIBITION OF CYTOPLASMIC DNA ACCUMULATION IN VACCINIA VIRUS INFECTION. A RADIOAUTOGRAPHIC STUDY.

Authors:  R M FRIEDMAN; J A SONNABEND; H MCDEVITT
Journal:  Proc Soc Exp Biol Med       Date:  1965-06

4.  Interferon produced by cultures of calf kidney cells.

Authors:  D A TYRRELL
Journal:  Nature       Date:  1959-08-08       Impact factor: 49.962

5.  Mechanisms of interferon induced transfer of viral resistance between animal cells.

Authors:  J E Blalock; S Baron
Journal:  J Gen Virol       Date:  1979-02       Impact factor: 3.891

6.  Enucleation and reconstruction of interferon-producing cells.

Authors:  D C Burke; G Veomett
Journal:  Proc Natl Acad Sci U S A       Date:  1977-08       Impact factor: 11.205

7.  pppA2'p5'A2'p5'A: an inhibitor of protein synthesis synthesized with an enzyme fraction from interferon-treated cells.

Authors:  I M Kerr; R E Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1978-01       Impact factor: 11.205

8.  Synthesis of low molecular weight inhibitor of protein synthesis with enzyme from interferon-treated cells.

Authors:  A G Hovanessian; R E Brown; I M Kerr
Journal:  Nature       Date:  1977-08-11       Impact factor: 49.962

9.  Isolation of two interferon-induced translational inhibitors: a protein kinase and an oligo-isoadenylate synthetase.

Authors:  A Zilberstein; A Kimchi; A Schmidt; M Revel
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

10.  Oligonucleotide inhibitor of protein synthesis made in extracts of interferon-treated chick embryo cells: comparison with the mouse low molecular weight inhibitor.

Authors:  L A Ball; C N White
Journal:  Proc Natl Acad Sci U S A       Date:  1978-03       Impact factor: 11.205

View more
  4 in total

1.  Diverse intracellular pathogens activate type III interferon expression from peroxisomes.

Authors:  Charlotte Odendall; Evelyn Dixit; Fabrizia Stavru; Helene Bierne; Kate M Franz; Ann Fiegen Durbin; Steeve Boulant; Lee Gehrke; Pascale Cossart; Jonathan C Kagan
Journal:  Nat Immunol       Date:  2014-06-22       Impact factor: 25.606

2.  Human but not mouse hepatocytes respond to interferon-lambda in vivo.

Authors:  Pascale Hermant; Céline Demarez; Tanel Mahlakõiv; Peter Staeheli; Philip Meuleman; Thomas Michiels
Journal:  PLoS One       Date:  2014-01-31       Impact factor: 3.240

3.  Species Specificity of Type III Interferon Activity and Development of a Sensitive Luciferase-Based Bioassay for Quantitation of Mouse Interferon-λ.

Authors:  Sophie Jacobs; Fanny Wavreil; Bert Schepens; Hans Henrik Gad; Rune Hartmann; Joana Rocha-Pereira; Johan Neyts; Xavier Saelens; Thomas Michiels
Journal:  J Interferon Cytokine Res       Date:  2018-10-18       Impact factor: 2.607

4.  Oncolytic activity of the rhabdovirus VSV-GP against prostate cancer.

Authors:  Carles Urbiola; Frédéric R Santer; Monika Petersson; Gabri van der Pluijm; Wolfgang Horninger; Patrik Erlmann; Guido Wollmann; Janine Kimpel; Zoran Culig; Dorothee von Laer
Journal:  Int J Cancer       Date:  2018-07-03       Impact factor: 7.396

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.